Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #269886 on NorthWest Biotherapeutics Inc (NWBO)
Lykiri
03/08/20 8:59 PM
#269890 RE: Dan88 #269886
Michael Ivan, MD, MBS Great talk this morning by Dr. de la Fuente @delaFuenteNOnc on IDH1 targeted drugs in gliomas! Excited for our phase 3 trial which just started for #lowgradegliomas here at UM (#firstinflorida). #braincancer #cureglioblastoma @SylvesterCancer @umneurosurgery @UMiamiHealth
Great talk this morning by Dr. de la Fuente @delaFuenteNOnc on IDH1 targeted drugs in gliomas! Excited for our phase 3 trial which just started for #lowgradegliomas here at UM (#firstinflorida). #braincancer #cureglioblastoma @SylvesterCancer @umneurosurgery @UMiamiHealth pic.twitter.com/uzBLZ8xBCD— Michael Ivan, MD, MBS, FAANS (@michaelivanmd) March 6, 2020
Great talk this morning by Dr. de la Fuente @delaFuenteNOnc on IDH1 targeted drugs in gliomas! Excited for our phase 3 trial which just started for #lowgradegliomas here at UM (#firstinflorida). #braincancer #cureglioblastoma @SylvesterCancer @umneurosurgery @UMiamiHealth pic.twitter.com/uzBLZ8xBCD